ArticlePLOS mental health2026
Dissecting multimodal predictors of psychosis risk and remission in youth at ultra‑high risk of developing psychosis: An exploratory study.
Article in PLOS mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early identification of individuals at risk of developing psychosis enables timely intervention and better clinical outcomes. Current approach relies on clinical assessments, such as the Comprehensive Assessment for At‑Risk Mental States (CAARMS), which provides an Ultra‑High‑Risk (UHR) classification but have limited predictive precision. Artificial intelligence (AI) models integrating neuroimaging, clinical, genetic, and biomolecular data show promise for improving prognostic accuracy, yet their clinical applicability remains uncertain. We systematically evaluated the contribution of six data modalities, ranging from socio‑environmental factors to polygenic risk scores, using data from 56 UHR participants in the Longitudinal Youth at‑Risk Study (LYRIKS) cohort. Modalities were iteratively included and excluded to generate candidate models tested on two tasks: (1) predicting transition to psychosis within 12 months and (2) predicting remission from UHR status within the same period. Statistical significance was assessed via permutation testing. Of the 56 UHR participants, 12 developed psychosis and 26 achieved remission from UHR status. The model combining CAARMS, socio-environmental risk factors, and social functioning (CAARMS + RISK + HiSoC) achieved the best overall performance for both predicting conversion (MCC = 0.71, SP = 0.93, SE = 0.78) and remission (MCC = 0.64, SP = 0.82, SE = 0.77), and was the only model to significantly outperform null models in the conversion task. Behavioural and socio‑environmental modalities demonstrate strong predictive value for forecasting outcomes in UHR within multimodal AI frameworks. While molecular and genetic modalities remain promising, further advances are needed to translate their high‑dimensional complexity into clinically useful predictive tools.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.